A. Regadera

Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34+ positive selection

I. Jarque, J. Rubia, G. Sanz, 2001, Bone Marrow Transplantation.

Infectious complications in patients undergoing unrelated donor bone marrow transplantation: experience from a single institution.

M. Sanz, J. Pemán, J. de la Rubia, 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Cutaneous promyelocytic sarcoma at sites of vascular access and marrow aspiration. A characteristic localization of chloromas in acute promyelocytic leukemia?

J. Cervera, M. Sanz, J. de la Rubia, 2000, Haematologica.

Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies.

P. Bolufer, E. Barragán, J. Cervera, 2001, Blood.

hematologic malignancies Standardized, unrelated donor cord blood transplantation in adults with

P. Bolufer, E. Barragán, J. Cervera, 2013 .

Recent improvements in outcome for elderly patients with de novo acute myeloblastic leukemia.

J. Cervera, M. Sanz, J. de la Rubia, 2001, Leukemia research.

ABO incompatibility does not influence transfusion requirements in patients undergoing single-unit umbilical cord blood transplantation

M. Sanz, J. Sanz, J. I. Lorenzo, 2017, Bone Marrow Transplantation.

Time and Cost of Hospitalisation for Salvage Therapy in Adults with Philadelphia Chromosome-Negative B Cell Precursor Relapsed or Refractory Acute Lymphoblastic Leukaemia in Spain

J. Cervera, M. Sanz, J. Sanz, 2018, PharmacoEconomics - Open.

RNA Sequencing Analysis for the Identification of a PCM1/PDGFRB Fusion Gene Responsive to Imatinib

E. Barragán, J. Cervera, M. Sanz, 2019, Acta Haematologica.

Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia

M. Ramírez, Arturo Pereira, F. Cervantes, 2018, British journal of haematology.

FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk myeloid malignancies.

J. Cervera, M. Sanz, J. de la Rubia, 2002, Leukemia research.